Skip to main content
. Author manuscript; available in PMC: 2017 Dec 19.
Published in final edited form as: Microb Drug Resist. 2014 Aug 12;21(2):121–129. doi: 10.1089/mdr.2014.0086

Table 3.

Changes Associated with Quinupristin–Dalfopristin Nonsusceptibility

Year Strain ID Serotype ERY CLD Q-Da Changes in L4c,d Changes in L22c,d Changes in 23S rRNAc Othere
1997 3179-97 09V 4 0.12 2.0
1997 1095-99 11A > 8 4 2.0 A2060C
2007 2008236056 19A > 32 > 2 2.0 e + m
2007 2008227074b 09N 1 0.06 3.0 Q67R R72G
2000 4339-00 19F 0.5 0.06 4.0 63KPWRQKGKGTGRAR74
2001 5663-01 19F 32 0.06 4.0 63KPWRQKGSQKGTGRAR74 m
2003 6766-04 12F 0.25 ≤ 0.03 4.0 63KPWRPWRQKGTGRAR74
2008 2008237895 07F 0.5 0.06 4.0 78AFANEGPTIAFANEGPTM86
2000 7697-03 23F 1 0.12 8.0 E30K
2001 2009216547 014 2 0.06 8.0 102KRTAHITRTAHITVA110
2001 6434-01 06A 2 0.06 8.0 102KRTAHITKRTAHIVA110
1996 0571-97 004 1 0.06 12.0 102KRTAHITKRTAHITVA110
2007 7799-07 11A > 32 1 12.0 C2613G
2010 2010223420 19A 4 0.06 12.0 102KRTAHITVRTAHITVA110
2008 2009208197 16F 1 0.06 16.0 85TMKRFRPRASFRPRAK94
2000 6356-00 06A 4 0.06 32.0 R103C
1995 3262-95 06A 2 ≤ 0.03 12.0 None
2001 5951-01 004 1 0.06 8.0 None
a

Determined by Etest.

b

This strain is nonsusceptible to linezolid (minimum inhibitory concentration = 4 μg/ml).

c

Relative to TIGR4.

d

Insertions are underlined.

e

ermT, ermA (subclass ermTR), ermB (e), mef (m), cfr, lsaC, and vgaA.